Hatem Amer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hatem Amer has a total of 406 co-authors. Here are the top co-authors by number of shared publications:
Mark D. Stegall
The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA
11 shared publicationsFernando G. Cosio
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
8 shared publicationsM D Stegall
7 shared publications- Andrew Bentall
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
6 shared publications - Fernando G. Cosio
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN
6 shared publications M. Stegall
Surgery, Transplant Center, Mayo Clinic, Rochester, MN
6 shared publications
Latest Publications
- 12 September 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (9) , e70679
Delayed Graft Function After Simultaneous Heart–Kidney Transplantation Across Heart Allocation Eras: Predictors and Impact on Kidney Graft Survival in a National Cohort
Background: Delayed graft function (DGF) is common after simultaneous heart–kidney (SHK) transplantation, yet its predictors and long‐term consequences in contemporary practice remain incompletely defined. We evaluated the incidence, determinants, and impact of DGF on kidney graft outcomes in a national SHK cohort. Methods: Using the Scientific Registry of Transplant Recipients, between 2014–2025, we identified adult SHK recipients. After exclusions, 1637 recipients were analyzed. Baseline characteristics were compared by DGF status. Multivariable logistic regression identified DGF predictors. Cox proportional hazards models assessed DGF association with death‐censored and overall kidney graft survival. Results: DGF occurred in 29.1% of recipients ( n = 477). Independent predictors of higher DGF odds included higher recipient BMI, pre‐transplant dialysis, longer cold ischemia time, and higher refitted KDRI (all p < 0.01). In the adjusted models for long‐term kidney graft outcomes, DGF was associated with higher death‐censored graft loss (HR 2.02, 95% CI 1.11–3.65; p = 0.021) and overall graft loss (HR 2.04, 95% CI 1.47–2.82; p < 0.001). DGF rates and graft outcomes did not differ by heart allocation era ( p = 0.179), and DGF was not associated with higher kidney ( p = 0.133) or heart rejection ( p = 0.848) at 1 year. Conclusion: DGF is frequent after SHK transplantation and identifies a high‐risk subgroup with substantially inferior long‐term kidney graft survival, independent of rejection and allocation era. Given the frequency of DGF and its adverse outcomes, future studies are needed to evaluate kidney‐after‐heart safety‐net utilization and post–heart‐transplant renal recovery to optimize outcomes and promote judicious kidney allocation in SHK candidates at high risk for DGF.
- 12 September 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (9) , e70679
Delayed Graft Function After Simultaneous Heart–Kidney Transplantation Across Heart Allocation Eras: Predictors and Impact on Kidney Graft Survival in a National Cohort
Background: Delayed graft function (DGF) is common after simultaneous heart–kidney (SHK) transplantation, yet its predictors and long‐term consequences in contemporary practice remain incompletely defined. We evaluated the incidence, determinants, and impact of DGF on kidney graft outcomes in a national SHK cohort. Methods: Using the Scientific Registry of Transplant Recipients, between 2014–2025, we identified adult SHK recipients. After exclusions, 1637 recipients were analyzed. Baseline characteristics were compared by DGF status. Multivariable logistic regression identified DGF predictors. Cox proportional hazards models assessed DGF association with death‐censored and overall kidney graft survival. Results: DGF occurred in 29.1% of recipients ( n = 477). Independent predictors of higher DGF odds included higher recipient BMI, pre‐transplant dialysis, longer cold ischemia time, and higher refitted KDRI (all p < 0.01). In the adjusted models for long‐term kidney graft outcomes, DGF was associated with higher death‐censored graft loss (HR 2.02, 95% CI 1.11–3.65; p = 0.021) and overall graft loss (HR 2.04, 95% CI 1.47–2.82; p < 0.001). DGF rates and graft outcomes did not differ by heart allocation era ( p = 0.179), and DGF was not associated with higher kidney ( p = 0.133) or heart rejection ( p = 0.848) at 1 year. Conclusion: DGF is frequent after SHK transplantation and identifies a high‐risk subgroup with substantially inferior long‐term kidney graft survival, independent of rejection and allocation era. Given the frequency of DGF and its adverse outcomes, future studies are needed to evaluate kidney‐after‐heart safety‐net utilization and post–heart‐transplant renal recovery to optimize outcomes and promote judicious kidney allocation in SHK candidates at high risk for DGF.
- Open Access
- 6 July 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (8) , e1976
Renal Function Decline After Vascularized Composite Allotransplantation
Background.: Chronic kidney disease (CKD) is a common complication of nonrenal transplantation, influencing recipients’ morbidity and mortality. The incidence of CKD varies depending on the transplanted organ. Recipients of vascularized composite allotransplantation (VCA) need lifelong immunosuppression similar to that of solid organ transplantation. This study investigated renal function in VCA recipients. Methods.: We studied 70 recipients from 17 centers (median follow-up: 8 y): 59 upper extremity, 10 face, and 1 penis transplant. Pretransplant and posttransplant clinical data and sera were collected to calculate the estimated glomerular filtration rate (eGFR) using the CKD Epidemiology collaboration 2021 formula. Results.: Pretransplantation, the median eGFR was 105.36 mL/min (range, 71.39–155.39 mL/min). By 3 mo posttransplant, the eGFR had significantly decreased to 78.42 mL/min (range, 32.49–130.74 mL/min; P = 0.001) before stabilizing. Despite higher tacrolimus levels at 3 mo, no correlation with eGFR was found. During follow-up, 17.1% of patients experienced a ≥50% eGFR decline, 10.9% progressed to CKD, and 4.7% developed end-stage kidney disease. Some risk factors were identified, but their responsibility could not be established with certainty because of the low number of severe renal outcomes. Conclusions.: Renal function declines in the majority of VCA recipients, but the function loss is lower compared with nonrenal solid organ transplantation recipients. Although no statistically significant correlation could be established between tacrolimus exposure and renal function decline, strategies aiming at minimizing calcineurin inhibitor exposure and avoiding other nephrotoxic causes are recommended to preserve long-term kidney function.
- 6 July 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (8) , e1976
Open AccessRenal Function Decline After Vascularized Composite Allotransplantation
Background.: Chronic kidney disease (CKD) is a common complication of nonrenal transplantation, influencing recipients’ morbidity and mortality. The incidence of CKD varies depending on the transplanted organ. Recipients of vascularized composite allotransplantation (VCA) need lifelong immunosuppression similar to that of solid organ transplantation. This study investigated renal function in VCA recipients. Methods.: We studied 70 recipients from 17 centers (median follow-up: 8 y): 59 upper extremity, 10 face, and 1 penis transplant. Pretransplant and posttransplant clinical data and sera were collected to calculate the estimated glomerular filtration rate (eGFR) using the CKD Epidemiology collaboration 2021 formula. Results.: Pretransplantation, the median eGFR was 105.36 mL/min (range, 71.39–155.39 mL/min). By 3 mo posttransplant, the eGFR had significantly decreased to 78.42 mL/min (range, 32.49–130.74 mL/min; P = 0.001) before stabilizing. Despite higher tacrolimus levels at 3 mo, no correlation with eGFR was found. During follow-up, 17.1% of patients experienced a ≥50% eGFR decline, 10.9% progressed to CKD, and 4.7% developed end-stage kidney disease. Some risk factors were identified, but their responsibility could not be established with certainty because of the low number of severe renal outcomes. Conclusions.: Renal function declines in the majority of VCA recipients, but the function loss is lower compared with nonrenal solid organ transplantation recipients. Although no statistically significant correlation could be established between tacrolimus exposure and renal function decline, strategies aiming at minimizing calcineurin inhibitor exposure and avoiding other nephrotoxic causes are recommended to preserve long-term kidney function.
- Open Access
- 19 March 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (4) , e1902
Transplantation Direct: The Official Journal of the International Society of Vascularized Composite Allotransplantation
- 19 March 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (4) , e1902
Open AccessTransplantation Direct: The Official Journal of the International Society of Vascularized Composite Allotransplantation
- 6 March 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (3) , e70288
Simultaneous Ureteral Ligation at the Time of Pediatric Kidney Transplantation: A Technical Report
Background: In pediatric kidney transplant recipients, native nephrectomy is sometimes performed to manage conditions such as polyuria, nephrotic syndrome, and recurrent infections. To minimize surgical morbidity, our center adopted a technique from the adult transplant program involving ligation of native ureters at the time of transplantation as an alternative to native nephrectomy in selected patients. Methods: This retrospective study describes our center's experience with pediatric patients who underwent ureteral ligation at transplantation between December 2008 and December 2022. Patient selection was based on clinical judgment rather than predefined criteria. Results: Sixteen patients underwent ureteral ligation, with polyuria (12/16) and proteinuria associated with focal segmental glomerulosclerosis (4/16) as the primary indications. Ligation was unilateral in 5 patients and bilateral in 11. The average follow‐up was 5.7 years. No operative complications directly attributable to ureteral ligation were observed, including native kidney pyelonephritis or need for reoperation. Although post‐transplant imaging often revealed hydronephrosis of the native kidneys, it had no clinical consequences. Late postoperative hypertension occurred in 31% of the ligation group compared to 47% of controls without ligation, while new‐onset hypertension was more common in the ligation group (18.8% vs. 5.1%). Pain scores postoperatively were comparable between groups. Conclusions: This technical report suggests that native ureteral ligation at pediatric kidney transplantation is feasible in selected patients but represents an empirical, non‐standard‐of‐care approach. Prospective comparative studies are needed to refine patient selection and assess long‐term outcomes.
- 6 March 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (3) , e70288
Simultaneous Ureteral Ligation at the Time of Pediatric Kidney Transplantation: A Technical Report
Background: In pediatric kidney transplant recipients, native nephrectomy is sometimes performed to manage conditions such as polyuria, nephrotic syndrome, and recurrent infections. To minimize surgical morbidity, our center adopted a technique from the adult transplant program involving ligation of native ureters at the time of transplantation as an alternative to native nephrectomy in selected patients. Methods: This retrospective study describes our center's experience with pediatric patients who underwent ureteral ligation at transplantation between December 2008 and December 2022. Patient selection was based on clinical judgment rather than predefined criteria. Results: Sixteen patients underwent ureteral ligation, with polyuria (12/16) and proteinuria associated with focal segmental glomerulosclerosis (4/16) as the primary indications. Ligation was unilateral in 5 patients and bilateral in 11. The average follow‐up was 5.7 years. No operative complications directly attributable to ureteral ligation were observed, including native kidney pyelonephritis or need for reoperation. Although post‐transplant imaging often revealed hydronephrosis of the native kidneys, it had no clinical consequences. Late postoperative hypertension occurred in 31% of the ligation group compared to 47% of controls without ligation, while new‐onset hypertension was more common in the ligation group (18.8% vs. 5.1%). Pain scores postoperatively were comparable between groups. Conclusions: This technical report suggests that native ureteral ligation at pediatric kidney transplantation is feasible in selected patients but represents an empirical, non‐standard‐of‐care approach. Prospective comparative studies are needed to refine patient selection and assess long‐term outcomes.
- 29 August 2023
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 83 (1) , 116
Best Practice for Induction of Immunosuppression in Patients Treated With Daratumumab Is to Be Determined
- 29 August 2023
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 83 (1) , 116
Best Practice for Induction of Immunosuppression in Patients Treated With Daratumumab Is to Be Determined
- 29 August 2023
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (2) , 329-330
What Can the Developing World (and Others) Learn From the Indian Experience in Crossing the ABO Blood Group Barrier in Kidney Transplantation
- 29 August 2023
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (2) , 329-330
What Can the Developing World (and Others) Learn From the Indian Experience in Crossing the ABO Blood Group Barrier in Kidney Transplantation
- Open Access
- 7 June 2023
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 7 (4) , 244-247
Maximizing Solid Organ and Face Transplant Procurement Team Coordination: The Posterior Tibial Artery Flap as an Ideal Sentinel Flap
- 7 June 2023
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 7 (4) , 244-247
Open AccessMaximizing Solid Organ and Face Transplant Procurement Team Coordination: The Posterior Tibial Artery Flap as an Ideal Sentinel Flap
- Open Access
- 4 January 2023
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 36 (4) , 1169-1174
Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression
Post-transplant recurrence of ANCA-associated vasculitis (AAV) is infrequent, with recurrence within weeks of transplantation being even rarer. We describe an unusual case of AAV recurrence within 2 weeks post-transplant. Our patient received a deceased donor kidney transplant (KDPI 60%) after 6 years on hemodialysis for end-stage renal disease from AAV. She was induced with thymoglobulin and steroids, and maintained on belatacept, mycophenolate and prednisone. Time-zero biopsy showed acute tubular injury. Due to persistent delayed graft function by post-operative day 14, she underwent repeat biopsy, which showed focal segmental necrotizing and crescentic glomerulonephritis, with positive MPO, PR3 and negative anti-glomerular basement membrane antibodies. As her findings were in keeping with recurrent AAV, she underwent induction with rituximab, prednisone and intravenous immunoglobulin, with repeat rituximab 14 days later because of increasing B-lymphocyte counts. Belatacept was replaced with tacrolimus due to concerns with autoimmunity. Fortunately, renal function began to recover 4 days after treatment. In addition to highlighting potential immunologic mechanisms in AAV and the use of rituximab in post-transplant recurrence, our case suggests that for systemic autoimmune disease, patients maintained on belatacept must be monitored closely for recurrence, particularly in the setting of delayed graft function. Graphical Abstract
- 4 January 2023
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 36 (4) , 1169-1174
Open AccessEarly post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression
Post-transplant recurrence of ANCA-associated vasculitis (AAV) is infrequent, with recurrence within weeks of transplantation being even rarer. We describe an unusual case of AAV recurrence within 2 weeks post-transplant. Our patient received a deceased donor kidney transplant (KDPI 60%) after 6 years on hemodialysis for end-stage renal disease from AAV. She was induced with thymoglobulin and steroids, and maintained on belatacept, mycophenolate and prednisone. Time-zero biopsy showed acute tubular injury. Due to persistent delayed graft function by post-operative day 14, she underwent repeat biopsy, which showed focal segmental necrotizing and crescentic glomerulonephritis, with positive MPO, PR3 and negative anti-glomerular basement membrane antibodies. As her findings were in keeping with recurrent AAV, she underwent induction with rituximab, prednisone and intravenous immunoglobulin, with repeat rituximab 14 days later because of increasing B-lymphocyte counts. Belatacept was replaced with tacrolimus due to concerns with autoimmunity. Fortunately, renal function began to recover 4 days after treatment. In addition to highlighting potential immunologic mechanisms in AAV and the use of rituximab in post-transplant recurrence, our case suggests that for systemic autoimmune disease, patients maintained on belatacept must be monitored closely for recurrence, particularly in the setting of delayed graft function. Graphical Abstract
- 1 June 2022
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 97 (6) , 1050-1053
The Chauvet Workgroup: A Resource for the Psychosocial Aspects of Reconstructive Transplantation
- 1 June 2022
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 97 (6) , 1050-1053
The Chauvet Workgroup: A Resource for the Psychosocial Aspects of Reconstructive Transplantation